Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.
While the PLCO Cancer Screening trial demonstrated no observed mortality benefit associated with screening for prostate cancer with prostate-specific antigen and rectal exam, the knowledge gained about prostate cancer and screening and resources developed in completing the trial make the trial a success.